Senior Software Engineer

Sonio announces FDA clearance of the 3rd version of Sonio Detect. Sonio SAS is thrilled to share that its revolutionary AI-powered solution, the third version of Sonio Detect, has received FDA 510(k) clearance. Sonio Detect is designed to ensure high-quality exams by automatically detecting views and anatomical structures, and verifying quality criteria of ultrasound images. Efficient workflows, quality assurance and anomaly detection have been its top priorities since founding Sonio. Today, Sonio SAS is reenforcing its commitment to Quality Assurance with the FDA clearance of the third version of Sonio Detect, which expanded the scope of its AI-powered image evaluation. What's new in Detect v3. Sonio Detect v3 introduces several new capabilities: * Expanded scope of automatically detected views: it detects 14 T1 views with 88.6% sensitivity and 98.1% specificity; and 40 T2/T3 views with 90.1% sensitivity and 99.3% specificity * Expanded scope of ISUOG/AIUM guidelines % coverage: Detect v3 now covers up to 65% of ISUOG and 65% AIUM T2/T3 detailed exam protocols without manual annotation, with a target roadmap set to cover 100% by next release * Expanded scope of automatically detected structures: while maintaining performance in detecting Brain and Thorax/Heart structures at T2/T3, scope has expanded to include 58 anatomical structures (15 at T1 and 43 at T2/T3) over various anatomical regions: brain, face, profile, thorax, heart, and placenta * Automatic localization of specific structures on the image to provide users more context on what AI detected * As with with Detect v2, Detect v3 continues to automatically detect placenta location and fetus sex The integration of Sonio Detect V3 into its platform is currently underway. While Sonio SAS is excited to bring these enhanced capabilities to its users in the coming months, Sonio SAS is committed to ensuring a seamless rollout and will share specific timing as soon as it's confirmed. Empowering quality care through ai-powered ultrasound. Sonio is an advanced AI-powered ultrasound reporting solution that standardizes fetal ultrasound quality through AIUM or site-specific templates, automated reporting, and intelligent quality checks. With customizable protocols, finding-based reporting templates, and clinical decision support features, the platform empowers healthcare providers to deliver consistent, high-quality care. Sonio gives both physicians and sonographers confidence in their daily practice while supporting liability and risk management. Sonio is designed to support practices in efforts to reduce avoidable errors, align exams with protocols, improve report coherence for smoother review, and reduce inter-sonographer variability. By automating repetitive tasks such as data entry and report generation, the solution is built to streamline workflows and free up valuable time for patient care, while providing objective signals to upskill sonographers over time. Its ambition is to bridge the gap between structure, view detection, and anomaly detection to improve both screening and diagnosis in the near future. Ready to improve your patient care? Contact Sonio SAS and discover Sonio, the next-generation of Prenatal Ultrasounds.

Sonio launches new ai-powered product suite to enhance maternal healthcare in the U.S.